Molecular biopathology of metaplastic, dysplastic, and neoplastic laryngeal epithelium.

In a large series of more than 100 cases of laryngeal carcinomas, the presence of steroid hormone receptors was demonstrated in the cytosol and in the nuclear fraction. Their presence was confirmed by the identification of estrogen receptor isophorms and by the detection of hormone-related proteins such as ER-D5. EGFr, and cathepsin D. These molecules were also variably expressed in normal, hyperplastic, and dysplastic epithelium. These data suggest a possible role of hormone receptors during laryngeal carcinogenesis. Finally, the presence of an Angiotensin II receptor was studied in neoplastic and preneoplastic laryngeal epithelium.

[1]  A. Muscella,et al.  Human larynx expresses isoforms of the oestrogen receptor. , 1996, Cancer letters.

[2]  E. Maiorano,et al.  Cathepsin D in laryngeal carcinoma. preliminary report. , 1995, Bollettino della Societa italiana di biologia sperimentale.

[3]  G. Colucci,et al.  Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx. , 1994, European journal of cancer. Part B, Oral oncology.

[4]  H. Earp,et al.  Regulation of cell proliferation and growth by angiotensin II. , 1994, Progress in growth factor research.

[5]  S. Marsigliante,et al.  Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone. , 1993, Cancer letters.

[6]  S. Marsigliante,et al.  Steroid receptor status in malignant and non-malignant larynx. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  R. Zeillinger,et al.  Expression of cathepsin D in head and neck cancer. , 1992, European journal of cancer.

[8]  T. Maudelonde,et al.  CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER , 1989, The Lancet.

[9]  I. Touitou,et al.  Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells , 1989, Molecular and Cellular Endocrinology.

[10]  K. Mccarty,et al.  Sex steroid receptor distribution in the human larynx and laryngeal carcinoma. , 1987, Archives of otolaryngology--head & neck surgery.

[11]  K. Yamamoto,et al.  Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. , 1987, The EMBO journal.

[12]  R. Rubens,et al.  Histochemical studies with an estrogen receptor-related protein in human breast tumors. , 1986, Cancer research.

[13]  T. Carey,et al.  Growth inhibition of laryngeal UM-SCC cell lines by tamoxifen. Comparison with effects on the MCF-7 breast cancer cell line. , 1986, Archives of otolaryngology--head & neck surgery.

[14]  K. Aitasalo,et al.  Steroid Hormone Receptors in Laryngeal Carcinoma , 1986, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[15]  R. King,et al.  Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. , 1985, Cancer research.

[16]  D. Appleton,et al.  Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. , 1985, Journal of clinical pathology.

[17]  R. King,et al.  Monoclonal antibodies against a component related to soluble estrogen receptor. , 1985, Cancer research.

[18]  W. McGuire,et al.  Androgen receptors and antiandrogen therapy for laryngeal carcinoma. , 1984, A M A Archives of Otolaryngology.

[19]  Sherman Mr,et al.  Mero-receptors: proteolytic fragments of receptors containing the steroid-binding site. , 1978 .